Watchful Waiting (for Asymptomatic Inguinal Hernia in Men)

Treatment for Inguinal, femoral, and abdominal hernia

Typical Dosage: Regular self-monitoring, occasional physician check-ups

Effectiveness
70%
Safety Score
85%
Clinical Trials
7
Participants
1.5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
85
DangerousModerateSafe
Treatment Details
Dosage Range
Regular self-monitoring, occasional physician check-ups
Time to Effect
Ongoing
Treatment Duration
Lifetime or until surgery becomes necessary
Evidence Quality
HIGH
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$150
Side Effect Mgmt:$50
Total Annual:$200
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.1
Comparison vs Elective Open Mesh Repair
Cost Difference
$-5,700/year
Less expensive
QALY Difference
-0.05 QALYs
Worse outcomes
Dominance
DOMINATESBetter + cheaper
Watchful Waiting (for Asymptomatic Inguinal Hernia in Men) Outcomes

for Inguinal, femoral, and abdominal hernia

Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+65%
Common Side Effects
Hernia progression/symptom increase
+35%
Hernia incarceration/strangulation (requiring emergency surgery)
+2%
Discomfort/pain (worsening)
+20%

Sources:

nih.gov
proquest.com
oaepublish.com

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov